A detailed history of Summit Trail Advisors, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 5,343 shares of PEN stock, worth $961,579. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,343
Previous 5,354 0.21%
Holding current value
$961,579
Previous $1.35 Million 11.44%
% of portfolio
0.03%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$220.09 - $273.15 $2,420 - $3,004
-11 Reduced 0.21%
5,343 $1.19 Million
Q4 2023

Feb 06, 2024

BUY
$181.44 - $260.22 $971,429 - $1.39 Million
5,354 New
5,354 $1.35 Million
Q1 2019

May 16, 2019

SELL
$115.84 - $160.31 $260,640 - $360,697
-2,250 Closed
0 $0
Q1 2018

May 22, 2018

SELL
$84.6 - $126.1 $29.2 Million - $43.5 Million
-344,925 Reduced 99.35%
2,250 $347,000
Q1 2018

May 21, 2018

BUY
$84.6 - $126.1 $29.4 Million - $43.8 Million
347,175 New
347,175 $347,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $6.82B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.